Cargando…

KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8(+) T-cell-dependent antitumor immunity

Background: Immune checkpoint blockers (ICBs) are revolutionized therapeutic strategies for cancer, but most patients with solid neoplasms remain resistant to ICBs, partly because of the difficulty in reversing the highly immunosuppressive tumor microenvironment (TME). Exploring the strategies for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qi, Liu, Zhou, Gao, Zhijie, Luo, Yao, Li, Fubing, Yang, ChuanYu, Wang, Tiantian, Meng, Xiangyu, Chen, Haijun, Li, Juanjuan, Kong, Yanjie, Dong, Chao, Sun, Si, Chen, Ceshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008740/ https://www.ncbi.nlm.nih.gov/pubmed/36923542 http://dx.doi.org/10.7150/thno.82182

Ejemplares similares

Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
por: Shi, Peiguo, et al.
Publicado: (2017)

Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer
por: Kong, Yanjie, et al.
Publicado: (2022)

Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis
por: Liu, Rong, et al.
Publicado: (2020)

DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis
por: Cui, Qiuxia, et al.
Publicado: (2023)

The roles and regulation of the KLF5 transcription factor in cancers
por: Luo, Yao, et al.
Publicado: (2021)

Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
por: Liu, Rong, et al.
Publicado: (2016)

The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27(Kip1)
por: Wang, Chunyan, et al.
Publicado: (2015)

Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers
por: Chen, Chuan-Huizi, et al.
Publicado: (2019)

Intrinsic PD‐L1 promotes antitumor activity of CD8(+) cytotoxic T lymphocytes via in cis interaction with CD80
por: Ding, Yuming, et al.
Publicado: (2022)

Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer
por: Zhao, Ping, et al.
Publicado: (2023)

Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1(+)CD8 T cells
por: Wang, Chao, et al.
Publicado: (2019)

Decitabine priming increases anti–PD-1 antitumor efficacy by promoting CD8(+) progenitor exhausted T cell expansion in tumor models
por: Li, Xiang, et al.
Publicado: (2023)

Follicular helper-T cells restore CD8(+)-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy
por: Niogret, Julie, et al.
Publicado: (2021)

Platycodon grandiflorum Triggers Antitumor Immunity by Restricting PD-1 Expression of CD8(+) T Cells in Local Tumor Microenvironment
por: Yang, Ruijie, et al.
Publicado: (2022)

The Impact of KLF2 Modulation on the Transcriptional Program and Function of CD8 T Cells
por: Preston, Gavin C., et al.
Publicado: (2013)

Egr2-independent, Klf1-mediated induction of PD-L1 in CD4(+) T cells
por: Teruya, Shuzo, et al.
Publicado: (2018)

The transcription factor ELF4 controls proliferation and homing of CD8(+) T cells via the Krüppel-like factors KLF4 and KLF2
por: Yamada, Takeshi, et al.
Publicado: (2009)

Creatine uptake regulates CD8 T cell antitumor immunity
por: Di Biase, Stefano, et al.
Publicado: (2019)

Variants of innate CD8(+) T cells are associated with Grip2 and Klf15 genes
por: Jo, Yuna, et al.
Publicado: (2020)

The Partial Role of KLF4 and KLF5 in Gastrointestinal Tumors
por: Li, Jun-Chen, et al.
Publicado: (2021)

Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell
por: Zhu, Xinhai, et al.
Publicado: (2023)

BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5
por: Qin, Junying, et al.
Publicado: (2015)

The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth
por: Jia, Yunlu, et al.
Publicado: (2018)

Characterization and phylogenetic analysis of Krüppel-like transcription factor (KLF) gene family in tree shrews (Tupaia belangeri chinensis)
por: Shao, Ming, et al.
Publicado: (2016)

CD8(+) T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma
por: Xu, Chun, et al.
Publicado: (2018)

Hypoxia and antitumor CD8(+) T cells: An incompatible alliance?
por: Vuillefroy de Silly, Romain, et al.
Publicado: (2016)

BRCA1 deficiency in mature CD8(+) T lymphocytes impairs antitumor immunity
por: Wu, Bogang, et al.
Publicado: (2023)

Circulating memory PD-1(+)CD8(+) T cells and PD-1(+)CD8(+)T/PD-1(+)CD4(+)T cell ratio predict response and outcome to immunotherapy in advanced gastric cancer patients
por: Liu, Jiang, et al.
Publicado: (2023)

Potentiating CD8(+) T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
por: Yuan, Juanjuan, et al.
Publicado: (2021)

Variable density of CD8+ and CD25+ programmed cell death-1 (PD-1) ligand (PD-L1) CD4+ T cells within the tumor microenvironment causes differential responses to the PD-1/PD-L1 blockade
por: Wu, Si-Pei, et al.
Publicado: (2015)

KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling
por: Li, Yandong, et al.
Publicado: (2020)

CXCR6 is required for antitumor efficacy of intratumoral CD8(+) T cell
por: Wang, Binglin, et al.
Publicado: (2021)

Correction to: Potentiating CD8(+) T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
por: Yuan, Juanjuan, et al.
Publicado: (2021)

Conditional Deletion of Pdcd1 Identifies the Cell-Intrinsic Action of PD-1 on Functional CD8 T Cell Subsets for Antitumor Efficacy
por: Raghavan, Sukanya, et al.
Publicado: (2021)

KLF8: so different in ovarian and breast cancer
por: Zhao, Jihe
Publicado: (2014)

Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8(+) T cell antitumor immunity
por: Li, Anqi, et al.
Publicado: (2022)

miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5
por: Zhou, Wenhui, et al.
Publicado: (2017)

Regulation of CD8(+) T Cells and Antitumor Immunity by Notch Signaling
por: Tsukumo, Shin-ichi, et al.
Publicado: (2018)

Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis
por: Li, Fubing, et al.
Publicado: (2022)

Checkpoint TIPE2 Limits the Helper Functions of NK Cells in Supporting Antitumor CD8(+) T Cells
por: Bi, Jiacheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_taf37i2g5e1lh5148f1vqop5v0